Wearable Continuous Ketone Monitors (CKM)

Microneedle sensors tracking real-time metabolic flexibility and ketosis.
Wearable Continuous Ketone Monitors (CKM)

Wearable continuous ketone monitors (CKM) are similar to continuous glucose monitors (CGMs) but specifically track ketone bodies like beta-hydroxybutyrate in real-time, providing continuous feedback on metabolic state and the efficiency of fasting or ketogenic diets. These devices use microneedle sensors that penetrate the skin minimally to measure ketone levels in interstitial fluid, enabling precise optimization of ketogenic diets and metabolic therapies for longevity and cognitive performance without the need for invasive finger-prick blood testing.

This innovation addresses the limitation where monitoring ketosis required frequent blood tests, making it difficult to track metabolic state continuously and optimize dietary interventions. By providing continuous monitoring, these devices enable users to understand how different foods, activities, and timing affect their metabolic state, allowing for more precise optimization of ketogenic diets and metabolic therapies. Companies are developing these devices, with some already available for specific applications.

The technology is particularly valuable for people following ketogenic diets, practicing intermittent fasting, or using metabolic therapies for health optimization, where understanding metabolic state in real-time can improve outcomes. As the technology improves and becomes more accessible, it could enable more effective metabolic interventions. However, ensuring accuracy, managing sensor lifespan, and making the technology affordable remain challenges. The technology represents an important tool for metabolic health optimization, but requires continued development to achieve the accuracy and user experience needed for widespread adoption. Success could make metabolic monitoring as accessible as glucose monitoring, enabling more people to optimize their metabolic health.

TRL
7/9Operational
Impact
3/5
Investment
3/5
Category
Hardware
Gene editing platforms, bioelectronic interfaces, and multi-omics scanners.